Health

Results: 1381-1392 of 10153

PR Newswire associated0

Hanmi Signs Licensing Deal with Lilly for sonefpeglutide (LAPSGLP-2 analog)

World Vape Day 2026: One Switch – Everyone Wins

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL

Number of shares and votes in BioArctic AB (publ) as of May 29, 2026

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report

Two arrested during the MHRA’s largest ever seizure of unlicensed weight loss medicines

£340 million pharmacy boost brings faster care to the high street

Holmusk Expands NeuroBlu to 46 Million Patients, Adding Depth and Biomarker Data Across Neurology and Behavioral Health

AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 2026

WITH OVER 6,000 LIVES SAVED, LIFEVAC EUROPE(R) CALLS FOR ITS ANTI-CHOKING DEVICES TO BECOME A MANDATORY ITEM IN FIRST AID KITS